Fuller & Thaler Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Fuller & Thaler Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.6M	Sell	1,499,584 -488	-0%	-$20.7K	0.17%	195
2025 Q4	$69.5M	Sell	1,500,072 -2,602	-0.2%	-$109K	0.23%	162
2025 Q3	$52.6M	Buy	1,502,674 +71,645	+5%	+$2.49M	0.18%	190
2025 Q2	$42.3M	Buy	1,431,029 +59,581	+4%	+$1.7M	0.15%	206
2025 Q1	$40.9M	Buy	1,371,448 +19,568	+1%	+$598K	0.16%	203
2024 Q4	$38.7M	Sell	1,351,880 -18,074	-1%	-$598K	0.15%	212
2024 Q3	$52.9M	Buy	1,369,954 +178,581	+15%	+$6.37M	0.21%	154
2024 Q2	$38.4M	Buy	1,191,373 +222,174	+23%	+$7.7M	0.16%	184
2024 Q1	$37.6M	Buy	+969,199	New	+$33.9M	0.16%	169

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fuller & Thaler Asset Management's COLL Position: Q1 2026 in Review

Fuller & Thaler Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 0.03% in Q1 2026, selling an estimated $20.7K and leaving 1,499,584 shares worth $49.6M. The position accounts for 0.17% of the portfolio, ranked #195.

Fuller & Thaler Asset Management first reported a position in COLL in Q1 2024 and has held it in 9 quarters since. The position peaked at $69.5M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Fuller & Thaler Asset Management held 1,499,584 shares of Collegium Pharmaceutical worth $49.6M as of Q1 2026.
Fuller & Thaler Asset Management sold 488 Collegium Pharmaceutical shares in Q1 2026, an estimated $20.7K.
Collegium Pharmaceutical made up 0.17% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #195 holding.
Fuller & Thaler Asset Management first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 9 quarters since.
Fuller & Thaler Asset Management's Collegium Pharmaceutical position peaked at $69.5M in Q4 2025.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.